argipressin, val(4)- has been researched along with arginine vasopressin in 13 studies
| Studies (argipressin, val(4)-) | Trials (argipressin, val(4)-) | Recent Studies (post-2010) (argipressin, val(4)-) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | argipressin, val(4)- (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haldar, J; Lowbridge, J; Manning, M; Sawyer, W | 1 |
| Andres, M; Ben Mimoun, M; Cheng, LL; Derick, S; Gaillard, RC; Giacomini, M; Guillon, G; Manning, M; Stoev, S; Szeto, HH; Voirol, MJ; Wo, NC | 1 |
| Liard, JF | 7 |
| Inenaga, K; Kaneko, T; Kannan, H; Kasai, M; Okuya, S; Uesugi, S; Yamashita, H | 1 |
| Cowley, AW; Liard, JF; Ott, C; Schwartz, J | 1 |
| Derdowska, I; Kupryszewski, G; Schwartz, J; Sobocinska, M | 1 |
| McGrath, BP; Schwartz, J; Shimizu, K | 1 |
13 other study(ies) available for argipressin, val(4)- and arginine vasopressin
| Article | Year |
|---|---|
[1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
Topics: Arginine Vasopressin; Diuresis; Structure-Activity Relationship; Vasopressins | 1977 |
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Catecholamines; Cattle; Cells, Cultured; CHO Cells; Chromaffin System; Corticosterone; Corticotropin-Releasing Hormone; Cricetinae; Diuresis; Female; Gene Expression; Humans; Pituitary Gland, Anterior; Rats; Rats, Wistar; Receptors, Oxytocin; Receptors, Vasopressin; Transfection | 2002 |
Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Hemodynamics; Male; Oxytocin; Phenylephrine; Receptors, Angiotensin; Receptors, Vasopressin; Vascular Resistance; Vasopressins | 1990 |
Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Deamino Arginine Vasopressin; Dogs; Drug Interactions; Hemodynamics; Indomethacin; Injections, Intravenous; Male; Receptors, Angiotensin; Receptors, Vasopressin; Vascular Resistance | 1988 |
Peripheral vasodilatation induced by a vasopressin analogue with selective V2-agonism in dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Dogs; Femoral Artery; Heart Rate; Hemodynamics; Male; Reference Values; Regional Blood Flow; Vascular Resistance; Vasodilation | 1989 |
Vasodilation induced by a specific vasopressin V2 agonist in dogs.
Topics: Animals; Arginine Vasopressin; Central Nervous System; Dogs; Hemodynamics; Receptors, Angiotensin; Receptors, Vasopressin; Regional Blood Flow; Vasodilator Agents | 1988 |
Effects of a specific antidiuretic agonist on cardiac output and its distribution in intact and anephric dogs.
Topics: Adipose Tissue; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Kidney; Male; Muscles; Nephrectomy; Regional Blood Flow; Vascular Resistance | 1988 |
Oxytocin predominantly excites putative oxytocin neurons in the rat supraoptic nucleus in vitro.
Topics: Action Potentials; Animals; Arginine Vasopressin; In Vitro Techniques; Male; Neurons; Oxytocin; Rats; Rats, Inbred Strains; Supraoptic Nucleus | 1987 |
Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Bone and Bones; Cardiac Output; Cardiovascular Physiological Phenomena; Cardiovascular System; Dehydration; Dogs; Hemodynamics; Kidney; Liver; Male; Vascular Resistance; Vasoconstriction | 1986 |
Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs.
Topics: Animals; Arginine Vasopressin; Diuresis; Dogs; Female; Hemodynamics; Male; Oxytocin; Pharmaceutical Vehicles; Pituitary Hormones, Anterior; Propranolol; Time Factors; Vasopressins | 1985 |
Structure--function studies of vasopressin analogues with D-3 pyridyl-alanine in position 2.
Topics: Adenylyl Cyclases; Alanine; Amino Acid Sequence; Animals; Arginine Vasopressin; Biological Assay; Corticotropin-Releasing Hormone; Cyclic AMP; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1995 |
L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
Topics: Animals; Arginine; Arginine Vasopressin; Bradykinin; Cyclic AMP; Deamino Arginine Vasopressin; Dogs; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasodilation; Vasopressins | 1994 |
Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
Topics: Animals; Arginine Vasopressin; Autonomic Nerve Block; Blood Pressure; Heart Rate; Male; Oxytocin; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Reflex | 1993 |